Jennison Associates LLC Edgewise Therapeutics, Inc. Transaction History
Jennison Associates LLC
- $141 Billion
- Q1 2025
A detailed history of Jennison Associates LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 128,746 shares of EWTX stock, worth $2.13 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
128,746Holding current value
$2.13 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
221Shares Held
98.7MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$248 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$147 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$102 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$99.5 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$82.7 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.04B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...